Service de Pneumologie Aigue Spécialisée et Cancérologie Thoracique - Hôpital Lyon-Sud
Pierre-Bénite, 69495, France
NCT Number: NCT03268980
* Tobacco is the leading risk factor for avoidable mortality in France and around the world. It is also the second cause of life with disability in the world and the leading preventable risk factor for cancer in France and worldwide. * The "Health Barometer" studies carried out for 25 years in France by Santé-Publique France assessed prevalence of smoking in the lay population. These studies showed that smoking prevalence has stabilized among 15-75 year olds (34.1% of current smokers) with a slight decrease in regular smoking (from 29.1% in 2010 to 28.2% in 2014). * Data on the prevalence of smoking among hospital staff are contradictory. Some studies find a higher prevalence of active smoking than the general population; others have a lower prevalence. However, it appears that an active prevention policy with hospital staff can significantly and rapidly reduce the prevalence of active smoking. * The prevalence of active smoking in patients is logically higher than in the general population (at comparable age). * The data on the prevalence of smoking among medical students are also contradictory. Yet, this population is a special interest group given their future investment in patient care. * Cannabis use also appears to be an independent risk factor for respiratory diseases and broncho-pulmonary cancers. Cannabis use among health students is not uncommon (11.5% of students). To our knowledge, the measurement of the prevalence of Cannabis use in an all-patient population of a hospital-university facility has never been achieved. * According to the health barometer 2014, about a quarter of 15-75 year olds have already tried electronic cigarettes and 6% are regular current users. Although the toxicity of the electronic cigarette and its interest in weaning remain controversial, its use to patients, staff or patients has been reported very little.
The aim of this study is to assess the impact of collective and individual tobacco control measures by measuring the prevalence of smoking on a given day at the "Hospices Civils de Lyon", among patients, staff and students present on a given day.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Pierre-Bénite, 69495, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
One-page questionnaire with 15 questions about tobacco habits
One-page questionnaire with 17 questions about tobacco habits
Time frame: One day
The aim of this study is to determine the proportion of active smoker / smoker weaned / non-smoker in each group (patients / hospital staff / students).
Data are collected by a questionnaire.
Hospices Civils de Lyon
Other
Study of Smoking Prevalence at the "Hospices Civils de Lyon"
Acronym: TABAC-HCL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07737587
Behavior, Pathologic Processes
Iğdır, Turkey (Türkiye)
View Trial DetailsNCT06191419
Behavior, Chemically-Induced Disorders
Lexington, Kentucky, United States
View Trial DetailsNCT05259566
Behavior, Smoking
New Haven, Connecticut, United States
View Trial DetailsNCT06169813
Behavior, Smoking
Cape Town, South Africa
View Trial Details